Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,066.00
Bid: 3,089.00
Ask: 3,091.00
Change: 67.00 (2.23%)
Spread: 2.00 (0.065%)
Open: 3,047.00
High: 3,117.00
Low: 3,043.00
Prev. Close: 2,999.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3i Group plc - Pre-close period briefing

1 Apr 2011 07:00

RNS Number : 0775E
3i Group PLC
01 April 2011
 



 

1 April 2011

 

 

3i Group plc - Pre-close period briefing

 

3i Group plc ("3i"), an international investor focused on Private Equity, Infrastructure and Debt Management, will be holding discussions with analysts and investors for the financial year end period ending 31 March 2011. This statement sets out the information that will be covered in those discussions. 3i expects to announce its results for the 12 months ending 31 March 2011 on 12 May 2011.

 

Commenting on the statement, 3i's Chief Executive, Michael Queen, said:

 

"We have made good strategic progress across our whole business. Overall, the private equity portfolio has performed well. There have, however, been marked regional differences, with strong growth in Northern Europe counterbalanced by weaker performance from UK companies. This regional dispersion in performance is due to a combination of macro and company specific factors."

 

The main topics that will be discussed with analysts and investors are set out below.

 

1. Investments and realisations

3i invested a total of £581 million in the 11 months to 28 February 2011, compared with £311 million in the equivalent period last year. Of this investment, £184 million was new investment, £244 million was further investment in the portfolio and the balance was capitalised interest.

 

Investment by business line was as follows:

 

9 months to

11 months to

11 months to

31 December

28 February

28 February

2010

2011 (total)

2010 (total)

£m

£m

£m

Private Equity

Buyouts*

436

476

185

Growth Capital

23

45

93

Infrastructure

15

15

2

Debt Management*

36

45

13

Non-core activities

-

-

18

Total

510

581

311

\* The Debt Warehouse, previously managed in Buyouts, has been transferred to the newly established Debt Management business line.

 

Realisation proceeds received by 3i totalled £491 million in the 11 months ended 28 February 2011 (2010: £998 million).

 

Realisation proceeds by business line were as follows:

 

9 months to

11 months to

11 months to

31 December

28 February

28 February

2010

2011 (total)

2010 (total)

£m

£m

£m

Private Equity

Buyouts*

168

168

191

Growth Capital

126

162

468

Infrastructure

1

1

46

Debt Management*

40

86

63

Non-core activities

63

74

230

Total

398

491

998

\* The Debt Warehouse, previously managed in Buyouts, has been transferred to the newly established Debt Management business line.

 

Total proceeds do not include the expected sales proceeds from the sales of MWM and Hyva, which together will be around £350 million. Realisations for the 11 month period to 28 February 2011 have been achieved at aggregate uplifts over 31 March 2010 carrying values of 24%.

 

2. Returns

As usual, an important element in the determination of 3i's results for the full year to 31 March 2011 will be the detailed valuation exercise carried out on its investment portfolio as at that date.

 

Although this process has not yet completed, it is apparent that strong unrealised profits in much of the portfolio, particularly in Northern Europe, will be materially offset by reductions in value in a small number of portfolio companies, principally in relation to UK assets.

 

As noted at the half year, discussions with the trustees of the UK defined benefits plan are continuing with respect to the triennial funding valuation to 30 June 2010. It is not expected that the outcome of these discussions will have an impact on returns for this period.

 

3. Cashflow and balance sheet

 

The Group had cash, cash deposits and undrawn committed facilities of £1.93 billion at 28 February 2011 (31 December 2010: £1.91 billion). Net divestment cash inflow in the two month period was £50 million. Net debt decreased by £45 million to £422 million (31 December 2010: £467 million).

 

4. 3i Debt Management/Mizuho Investment Management

 

During the period, the completion of the acquisition of Mizuho Investment Management (UK) Limited ("MIM") from Mizuho Corporate Bank, Ltd was announced. MIM was one of Europe's leading debt management businesses with assets under management ("AUM") of £3.7 billion as at 31 March 2010. 3i's existing debt management activities were merged with MIM to form a distinct business line, 3i Debt Management.

 

Ends

 

 

For information please contact:

 

Patrick Dunne

Group Communications Director3i Group plc

020 7975 3566

Kathryn van der Kroft

3i Press Office

020 7975 3021

 

This statement aims to give an indication of certain key elements of the Company's performance for the 11 months to 28 February 2011. These indications reflect the Board's current view. They are subject to a number of risks and uncertainties and could change. In particular, an important element in the determination of 3i's results for the 12 months to 31 March 2011 is the detailed valuation exercise carried out on its investment portfolio as at that date. The final results for the 12 months to 31 March 2011 may differ accordingly. Factors which could cause or contribute to such differences include, but are not limited to, general economic and market conditions and specific factors affecting the financial prospects or performance of individual investments within 3i's portfolio.

 

This pre-close briefing is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration and any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from the issuer or selling security holder and that will contain detailed information about the company and management, as well as financial statements.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDKDDQABKDCNN
Date   Source Headline
28th Jun 20243:01 pmRNSTotal Voting Rights
28th Jun 20242:25 pmRNSDirector/PDMR Shareholding
28th Jun 20241:47 pmRNSDirector/PDMR Shareholding
28th Jun 20248:06 amRNSDirector/PDMR Shareholding
27th Jun 20243:34 pmRNSDirector/PDMR Shareholding
27th Jun 20243:05 pmRNSDoc re. AGM Resolutions
27th Jun 20243:04 pmRNSResult of AGM
27th Jun 20242:23 pmRNSHolding(s) in Company
27th Jun 20247:00 amRNSAGM and portfolio update
25th Jun 20249:27 amRNSHolding(s) in Company
21st Jun 20241:55 pmRNSHolding(s) in Company
7th Jun 202411:17 amRNSBlock listing Interim Review
5th Jun 20246:01 pmRNSDirector/PDMR Shareholding
4th Jun 20249:19 amRNSDirector/PDMR Shareholding
3rd Jun 202412:42 pmRNSDirector/PDMR Shareholding
31st May 20244:58 pmRNSTotal Voting Rights
31st May 20244:57 pmRNSDirector/PDMR Shareholding
31st May 20244:55 pmRNSDirector/PDMR Shareholding
22nd May 20243:32 pmRNSDoc Re: 2024 Notice of AGM
16th May 20243:47 pmRNSDirector/PDMR Shareholding
16th May 20249:41 amRNSDoc re. 2024 Annual Report and Accounts
14th May 20242:43 pmRNSDirector/PDMR Shareholding
10th May 202411:47 amRNSDirector/PDMR Shareholding
9th May 20247:00 amRNSResults for the year to 31 March 2024
1st May 20248:58 amRNSDirector/PDMR Shareholding
30th Apr 20244:34 pmRNSTotal Voting Rights
2nd Apr 20248:01 amRNSPortfolio Update
28th Mar 20241:02 pmRNSTotal Voting Rights
28th Mar 20241:00 pmRNSDirector/PDMR Shareholding
21st Mar 20241:53 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 202410:11 amRNSDirector/PDMR Shareholding
29th Feb 20244:21 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNS3i Group plc - Q3 performance update
31st Jan 20244:17 pmRNSTotal Voting Rights
31st Jan 20244:14 pmRNSDirector/PDMR Shareholding
4th Jan 20243:36 pmRNSTotal Voting Rights
4th Jan 20243:35 pmRNSDirector/PDMR Shareholding
3rd Jan 202412:00 pmRNSPortfolio Update
8th Dec 20231:11 pmRNSBlock listing Interim Review
30th Nov 20234:55 pmRNSTotal Voting Rights
30th Nov 20234:51 pmRNSDirector/PDMR Shareholding
23rd Nov 202311:11 amRNSDirector Declaration
20th Nov 20239:13 amRNSDirector Declaration
9th Nov 20232:29 pmRNSDirector/PDMR Shareholding
9th Nov 202311:49 amRNSDoc re. Half Yearly Report 2023
9th Nov 20237:00 amRNSHalf-year Report
31st Oct 20233:29 pmRNSTotal Voting Rights
31st Oct 20233:27 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.